Role of vitamin D supplementation in lung function testing and exercise capacity

Ravi Shekhar Jha (Gurgaon, India), Ravi Shekhar Jha

Source: International Congress 2016 – Functional assessment of the airways
Session: Functional assessment of the airways
Session type: Thematic Poster
Number: 4141
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ravi Shekhar Jha (Gurgaon, India), Ravi Shekhar Jha. Role of vitamin D supplementation in lung function testing and exercise capacity. Eur Respir J 2016; 48: Suppl. 60, 4141

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vitamin D deficiency is associated with rapid decline in exercise capacity in male patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Vitamin D status and longitudinal lung function decline in the Lung Health Study
Source: Eur Respir J 2011; 37: 238
Year: 2011



Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Total dietary antioxidant capacity is associated with lung function volumes in women
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Genetic influences on lung function decline in AATD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015

Non-invasive measures to detect ventilatory limitation during exercise
Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement
Year: 2015

The effect of Vitamin D deficiency on lung function in current smoker COPD patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Association of heart rate recovery after exercise test with exercise capacity in patients with stable COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

The oxygen uptake efficiency in patients with stable COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Decline in lung function in patients with alpha-1-antitrypsin deficiency and airflow obstruction
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

The [bdquo]frequent exacerbator“ phenotype: Endothelial dysfunction and functional status
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


Lung clearance index in alpha-1-antitrypsin deficiency - A follow up
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Effect of pulmonary rehabilitation on cardiac function during exercise in COPD
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013

Influence of the association of smoking, COPD and rpulmonary tuberculosis on diffusion lung capacity
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015


Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Pulmonary function tests, exercise capacity and health status in GOLD A, B, C, D groups
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013

Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Predictive factors of exercise capacity decline in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013


The effects of endogenous and exogenous vitamin D on the rate of mature elastin degradation in COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016